Thursday, August 6 at 10:00 BST | 11:00 CEST

Preeclampsia remains a leading cause of maternal and fetal morbidity and mortality worldwide, placing a significant burden on families and healthcare systems. Despite its adverse impact, early and accurate detection has long been a challenge. This educational webinar will explore how sFlt-1 and PlGF can help support more effective clinical decision-making to improve patient outcomes.

Join Dr. Stefan Verlohren, a leading expert in maternal-fetal medicine, as he provides an overview of the development and progression of preeclampsia. He will then examine through case study examples how the sFlt-1/PlGF ratio (PE ratio) is used in different clinical settings to assess risk and manage patients.

In addition, Dr. Verlohren will explain how the different clinical utilities of the PE ratio are used in a holistic, integrated approach for helping to improve outcomes for both mother and baby.

Designed for lab professionals and clinicians, this webinar will highlight the critical role of laboratory diagnostics in providing more effective preeclampsia patient care.

 

Key learning objectives:

Following this webinar, you will be able to:

  • Summarize the pathophysiology of preeclampsia and the clinical utility of the PE ratio
  • Explain the PE ratio clinical value in the short-term prediction and diagnosis of preeclampsia
  • Describe the clinically oriented, integrated approach of the PE ratio spanning early risk assessment, biomarker-driven prediction, and outcome-focused monitoring

Who should attend?

  • Obstetricians and maternal-fetal medicine specialists
  • Clinical pathologists and laboratory directors
  • Clinical chemists and medical technologists
  • Women’s health providers
  • Hospital administrators and care coordinators
  • Researchers and healthcare policymakers
  • Medical science liaisons and medical affairs professionals
  • Professionals involved in diagnostic test implementation or maternal risk stratification

 

Accreditation statement

SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Webinar details

  • Cost: Free to attend
  • Location: Online
  • Duration: 60 minutes
  • Instruction level: Intermediate

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.

Disclaimer

This presentation reflects the personal opinion of the author and may not correspond to the opinion of Siemens Healthineers. The clinical utility mentioned during this scientific webinar may be subject to various government regulations and may not be available in all locations. This presentation is not intended for a US audience.

Results from case studies are not predictive of outcomes in other cases. Results in other cases may vary.

Presenters

Stefan Verlohren, MD, Ph.D., DEGUM
Stefan Verlohren, MD, Ph.D., DEGUM

Chairman and Director, Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Prof. Dr. med. Stefan Verlohren is Chairman and Director of the Department of Obstetrics and Fetal Medicine at the University Medical Center Hamburg-Eppendorf, one of Germany’s leading centers for perinatal care. He received his medical training at Charité – University Medicine Berlin and St. George’s Hospital, London, and specialized in Maternal-Fetal Medicine. His clinical expertise focuses on the management of high-risk pregnancies and the prenatal diagnosis and therapy of fetal malformations. Prof. Verlohren’s primary research interest lies in preeclampsia, where he has contributed extensively to both basic and clinical research, publishing numerous studies in the field. He is a member of the ISSHP, currently working on the international preeclampsia guideline revision.
Lucy Lawrence
Lucy Lawrence

Science Editor

SelectScience

Register

Note: By completing this form, you will receive a free membership to SelectScience® and The Scientists’ Channel®. SelectScience is a trade organisation, we do not provide services to consumers and membership is for business purposes only. As a member you must provide us with a corporate email address to enable us (and our advertisers and sponsors) to contact you for marketing purposes. You can opt-out of marketing at any time. See our Privacy Policy

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

* Required Fields